MedTrace Logo

Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection

NCT02281721 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-07-14

No results posted yet for this study

Summary

The purpose of this observational post-marketing registry will be to collect and analyze safety, effectiveness, and quality of life outcomes, during and after treatment with the Surpass Flow Diverter. Health Economics assessments (cost data) will also be collected and analyzed.

Conditions

  • Cerebral Aneurysm

Interventions

DEVICE

Surpass Flow Diverter(s)

Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)

Sponsors & Collaborators

  • Stryker Neurovascular

    lead INDUSTRY

Principal Investigators

  • Patrick A Brouwer, MD · Karolinska Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-18
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Belgium
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02281721 on ClinicalTrials.gov